XML 70 R61.htm IDEA: XBRL DOCUMENT v3.22.2.2
Financing Arrangements - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended
Jan. 31, 2022
May 31, 2021
Jun. 30, 2022
Jun. 30, 2022
Jun. 30, 2021
Jun. 02, 2022
Dec. 31, 2021
Mar. 31, 2021
Line of Credit Facility [Line Items]                
Debt issuance costs   $ 2,800,000 $ 2,117,000 $ 2,117,000     $ 1,618,000  
Amortization of debt issuance cost       $ 667,000 [1] $ 0      
Common Stock warrants [Member]                
Line of Credit Facility [Line Items]                
Class of warrants issued during period           783,129    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights     (783,129) (783,129)       (313,252)
Loan and Security Agreement [Member]                
Line of Credit Facility [Line Items]                
Debt Instrument, Interest Rate, Stated Percentage   11.00%            
Debt instrument payment fee, Percentage   2.75%            
Interest expense     $ 1,200,000 $ 2,400,000        
Accretion Expense     88,900 134,800        
Debt Related Commitment Fees     68,000 116,300        
Amortization of debt issuance cost     179,700 415,600        
unamortized issuance cost     $ 2,800,000 $ 2,800,000        
Debt Instrument, Frequency of Periodic Payment   payable monthly            
Loan and Security Agreement [Member] | Prime Rate [Member]                
Line of Credit Facility [Line Items]                
Debt Instrument, Description of Variable Rate Basis   US Prime Rate plus 7.50% per annum            
Debt Instrument, Variable Rate   7.50%            
Loan and Security Agreement [Member] | Maximum [Member]                
Line of Credit Facility [Line Items]                
Debt Instrument, Interest Rate, Stated Percentage     23.70% 23.70%        
Loan and Security Agreement [Member] | Minimum [Member]                
Line of Credit Facility [Line Items]                
Debt Instrument, Interest Rate, Stated Percentage     17.83% 17.83%        
Tranche A [Member] | Loan and Security Agreement [Member] | Venture Capital [Member]                
Line of Credit Facility [Line Items]                
Line of Credit Facility, Maximum Borrowing Capacity               $ 12,000,000
Tranche B [Member] | Loan and Security Agreement [Member] | Venture Capital [Member]                
Line of Credit Facility [Line Items]                
Line of Credit Facility, Maximum Borrowing Capacity   $ 15,000,000            
Line of Credit Facility, Current Borrowing Capacity   8,000,000            
Line of Credit Facility, Remaining Borrowing Capacity   7,000,000            
Withdrawn Credit Facility   $ 7,000,000            
Class of warrants issued during period   995,099            
Tranche B [Member] | Loan and Security Agreement [Member] | Maximum [Member] | Venture Capital [Member]                
Line of Credit Facility [Line Items]                
Debt Instrument, Term   48 months            
Tranche B [Member] | Loan and Security Agreement [Member] | Minimum [Member] | Venture Capital [Member]                
Line of Credit Facility [Line Items]                
Debt Instrument, Term   19 months            
Tranche C [Member]                
Line of Credit Facility [Line Items]                
Debt Instrument, Interest Rate, Stated Percentage 11.00%              
Debt Related Commitment Fees $ 1,000,000              
Debt Instrument, Face Amount $ 5,000,000              
Debt Instrument, Payment Terms 19 months              
Debt Instrument, Frequency of Periodic Payment payable monthly              
Debt Instrument, Maturity Date Feb. 01, 2026              
Percentage of debt related cost paid upon the consummation of merger 20              
Debt instrument, repurchase amount $ 75,000,000              
Debt instrument, fee amount $ 5,000,000              
Tranche C [Member] | Prime Rate [Member]                
Line of Credit Facility [Line Items]                
Debt Instrument, Description of Variable Rate Basis US Prime Rate plus 7.50% per annum              
Debt Instrument, Variable Rate 7.50%              
[1] For discussion on the restatement adjustments, see Note 1 — Description of Business — Restatement of Condensed Consolidated Financial Statements and Immaterial Correction of Prior-Period Errors